New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk

Author:

Graham Ian1,Shear Chuck2,De Graeff Pieter34,Boulton Caroline5,Catapano Alberico L6,Stough Wendy Gattis7,Carlsson Stefan C8,De Backer Guy9,Emmerich Joseph10,Greenfeder Scott11,Kim Albert M12,Lautsch Dominik13,Nguyen Tu14,Nissen Steven E15,Prasad Krishna16,Ray Kausik K17,Robinson Jennifer G18,Sasiela William J19,Bruins Slot Karsten20,Stroes Erik21,Thuren Tom5,Van der Schueren Bart22,Velkovski-Rouyer Maja13,Wasserman Scott M23,Wiklund Olov24,Zouridakis Emmanouil16,Clement-Baudena Ghislaine,Gropper Savion,Hamer Andrew,Molemans Bart,Sourdille Timothée,Tahbaz Arash,Thorstensen Cathrine,

Affiliation:

1. Trinity College, Adelaide Health Foundation, Tallaght Hospital, Dublin 24, Ireland

2. Global Product Development/Internal Medicine, Pfizer, Inc., 235 E. 42nd Street, New York, New York 10017, NY, USA

3. Dutch Medicines Evaluation Board (CBG-MEB), Graadt Van Roggenweg 500, 3531 AH Utrecht, The Netherlands

4. Department of Pharmacy and Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands

5. Novartis Pharma AG, Asklepios 8, 4056 Basel, Switzerland

6. Department of Pharmacological and Biomolecular Sciences and Multimedica IRCCS, University of Milan, via Balzaretti 9, 20133 Milano, Italy

7. Departments of Clinical Research and Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, 217 Main St., Buies Creek, NC 27506, USA

8. Cardiovascular Pharmacology, AstraZeneca, Pepparredsleden 1, SE-431 83 Mölndal, Sweden

9. Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, University Hospital, K3, 4th floor, De Pintelaan 185, B9000 Ghent, Belgium

10. Université Paris-Descartes, Cochin-Hôtel Dieu Hospital, French National Agency for Medicines and Health Products Safety, 143/147, Boulevard, Anatole France 93285, Saint-Denis, France

11. Regulatory Affairs, Daiichi-Sankyo, 211 Mt. Airy Road, Basking Ridge, NJ 07920, USA

12. Internal Medicine Research Unit, Pfizer, Inc., 1 Portland St., 4th floor, Cambridge, MA 02139, USA

13. Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA

14. Sanofi, 55 Corporate Drive, Bridgewater, NJ, USA

15. Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA

16. Licensing Division, United Kingdom Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London SW1W 9SZ, UK

17. Department of Primary Care and Public Health, Imperial College, 323 Reynolds Building, Room 320, Charing Cross Hospital, London W68RF, UK

18. Department of Epidemiology, College of Public Health, University of Iowa, 145 N. Riverside Dr S455 CPHB, Iowa City, IA 52242, USA

19. Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA

20. Oslo University Hospital, Ullevål, Medical Department, Postboks 4956 Nydalen, 0424 Oslo, Norway

21. Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

22. Laboratory of Experimental Medicine and Endocrinology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium

23. Amgen, One Amgen Center Drive, MS 38.2.C, Thousand Oaks, CA 91320, USA

24. Wallenberg Laboratory, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3